Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH)

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / Common Stock
Shares outstanding
46,377,939
Total 13F shares
13,322,195
Share change
+2,728,628
Total reported value
$234,151,768
Price per share
$17.58
Number of holders
85
Value change
+$48,772,625
Number of buys
65
Number of sells
17

Institutional Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q2 2015

As of 30 Jun 2015, Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) was held by 85 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,322,195 shares. The largest 10 holders included FMR LLC, FEDERATED INVESTORS INC /PA/, Broadfin Capital, LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, JPMORGAN CHASE & CO, DEERFIELD MANAGEMENT CO, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, STATE STREET CORP, and RENAISSANCE TECHNOLOGIES LLC. This page lists 85 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.